China approves AstraZeneca’s lung cancer drug – Times of India
China has approved AstraZeneca drug, Imfinzi, to treat an aggressive type of lung cancer in adults, the group said on Monday, in a boost to its efforts to tackle the disease. The drug's use with chemotherapy for adult patients with…